Skip to main content

Bradley Bowers

Analyst

Mizuho Securities

Equibles does not estimate personal net worth.

About Bradley Bowers

Bradley Bowers is recorded as Analyst at Mizuho Securities. Bradley Bowers has spoken on 10 earnings calls across 6 companies, most recently for Castle Biosciences Inc on November 5, 2026. Those appearances were for Tempus AI, Inc. (TEM), GRAIL, Inc. (GRAL), Teleflex Inc (TFX), Guardant Health, Inc. (GH), Castle Biosciences Inc (CSTL) and 1 other company. The companies whose calls Bradley Bowers spoke on are classified in the Healthcare sector.

Bradley Bowers on recent calls

“Just wanted to ask on Tissue Cipher here, you know, obviously a nice step up in, you know, what's typically, you know, I guess a procedurally... You know, seasonally, like a little bit slower, 3Q versus 2Q. Just wanted to hear about, you know, what you're seeing in that business in terms of trend, how we should kind…”
Analyst — Mizuho, Castle Biosciences Q3 2026 Earnings Call ·
“Just wanted to maybe ask another one on MRD while we're here. You know, definitely understand the timing with respect to, you know, how much you're getting paid per test and colorectal is a big unlock.”
Analyst — Mizuho, Tempus Third Quarter 2026 Earnings Conference Call ·
“Maybe just wanted to click on the Salesforce expansion, obviously a pull forward of some of the costs. Just wanted to hear about why the timing is right. You know, seemingly, you know, the first part of 2027 timeline seems coincident with expected productivity ramp.”
Analyst — Mizuho, GRAIL, Inc. Q2 FY2026 Earnings Call ·
“Just wanted to double-click on interventional. Obviously, modeling is a little choppy, but it was the only one that was a little bit short of our model, but obviously the ramp is expected.”
Analyst — Mizuho, Teleflex Inc Q1 FY2026 Earnings Call ·
“Just wanted to maybe double click on where you're kind of seeing the reveal volume growth you know the pricing doesn't lend itself to be you know in medicare crc but maybe i'm wrong uh just based on k well checks you know that area may be preferring tissue just wanted to see if you know where you're kind of seeing…”
Analyst — Mizuho, Guardant Health, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • Mizuho Securities

    Analyst

    Source not stated

    Current

Company network

Recent activity